Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.
about
Management of cardiovascular complications in systemic lupus erythematosus.Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease.Endothelial dysfunction in chronic inflammatory diseasesMicrocirculation as determined by iontophoresis in SLE-patients and controls.Endothelial nitric oxide synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and MCP1 production in murine lupus nephritisImaging of cardiovascular complications in patients with systemic lupus erythematosus.The Effects of Tetrahydro-iso-alpha Acids and Niacin on Monocyte-Edothelial Cell Interactions and Flow-mediated Vasodilation.NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis.Endothelial function in children with a history of henoch schonlein purpuraImbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus.Cardiovascular benefits of habitual exercise in systemic lupus erythematosus: a review.Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.Relationship between endothelial dysfunction and microalbuminuria in familial Mediterranean fever.Endothelial dysfunction in systemic lupus erythematosus - a case-control study and an updated meta-analysis and meta-regression.Increased pulse wave velocity and carotid intima-media thickness in patients with ulcerative colitis.Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus.Effect of ezetimibe plus pravastatin on endothelial dysfunction in patients with systemic lupus erythematosus.Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients.Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus
P2860
Q33730536-C88C6848-2DB2-4D8A-8158-005A2433D17FQ34027430-FDD2BC9D-9D0C-4DD3-984E-8CED4D7FA8D7Q34072179-5B88FB8C-0438-4B72-A32A-749FD6C2DE66Q34194913-77AD178D-AC0C-4421-8959-03F321756639Q34760611-3BCEE41E-1878-4575-A83E-0942F76CA90EQ36052795-9DB1EE1D-BCB3-4A02-834D-9B05FD0854BDQ37323896-298EB1D2-8A0A-4029-ABCF-30A3776746FAQ37341275-0FD46C92-574B-418B-817F-75526301C171Q37587183-CB1D5F3A-B6A2-44DF-A3ED-759613398F02Q37699812-BC789445-C85F-48EF-9A1B-2C9D065DE9CDQ38092982-96A143EB-B61F-49D3-B363-AEF5A141E417Q38162490-C7797485-9A70-402C-BAE1-D65DBD7F4451Q40086213-E08F1CA9-2957-4A1C-A2BB-7A13FC065B0DQ41260389-8C8127CF-CF13-44DE-839A-50880071C9EAQ42270428-3F3CC0F9-0830-4D72-B5FA-0BFF777A8B97Q44897123-3DCDB771-0A08-4409-8F8F-B16A4F524B50Q50228698-D2496C80-935A-4FA3-93DC-4FF1B648FA1EQ50950582-0D0966A1-1053-480B-B188-F7EE8C7906DAQ51550154-193DFD68-649F-4471-BDB6-DA2E3B658055Q58190241-AE9DCED9-5631-4F2D-A4C6-7AC2580D9BC5
P2860
Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Reduced flow-mediated vasodila ...... mplications in lupus patients.
@ast
Reduced flow-mediated vasodila ...... mplications in lupus patients.
@en
type
label
Reduced flow-mediated vasodila ...... mplications in lupus patients.
@ast
Reduced flow-mediated vasodila ...... mplications in lupus patients.
@en
prefLabel
Reduced flow-mediated vasodila ...... mplications in lupus patients.
@ast
Reduced flow-mediated vasodila ...... mplications in lupus patients.
@en
P2093
P1476
Reduced flow-mediated vasodila ...... mplications in lupus patients.
@en
P2093
Emese Kiss
Gyula Szegedi
Harjit Bhattoa
Henrietta Der
Pal Soltesz
Tunde Tarr
Zsolt Kocsis
P304
P356
10.1016/J.JAUT.2006.09.008
P577
2006-11-07T00:00:00Z